Keyword: monoclonal antibodies (mAbs)
News
23.05.2024
-
Biogen and Human Immunology Biosciences (HI-Bio), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune...
News
28.03.2024
-
Aragen, a CRDMO, has launched the first phase of its biologics manufacturing facility in Bangalore, India. The $30 million project, executed by its subsidiary Aragen...
News
29.03.2016
- French firms Novasep and GTP Technology are combining their services and expertise to advance production of monoclonal antibodies (mAbs). The partnership is particularly targeting...
News
16.01.2015
- Under a deal just signed, German drugmaker Boehringer Ingelheim will offer its production capabilities for monoclonal antibodies to French pharmaceutical producer Sanofi to support...
